Datastring · Newsroom
Letermovir Market set to hit $597.8 million by 2035
Industry revenue for Letermovir is estimated to rise to $597.8 million by 2035 from $253.8 million of 2024. The revenue growth of market players is expected to average at 8.1% annually for the period 2024 to 2035.September 3, 2025
Levobunolol Hydrochloride Market set to hit $373.6 million by 2035
Industry revenue for Levobunolol Hydrochloride is estimated to rise to $373.6 million by 2035 from $213.9 million of 2024. The revenue growth of market players is expected to average at 5.2% annually for the period 2024 to 2035.September 3, 2025
Levalbuterol Market set to hit $432.0 million by 2035
Industry revenue for Levalbuterol is estimated to rise to $432.0 million by 2035 from $222.9 million of 2024. The revenue growth of market players is expected to average at 6.2% annually for the period 2024 to 2035.September 3, 2025
Lemborexant Market set to hit $691.9 million by 2035
Industry revenue for Lemborexant is estimated to rise to $691.9 million by 2035 from $332.1 million of 2024. The revenue growth of market players is expected to average at 6.9% annually for the period 2024 to 2035.September 3, 2025
Lovotibeglogene Autotemcel Market set to hit $1063.3 million by 2035
Industry revenue for Lovotibeglogene Autotemcel is estimated to rise to $1063.3 million by 2035 from $308.7 million of 2024. The revenue growth of market players is expected to average at 11.9% annually for the period 2024 to 2035.September 2, 2025
Levocarnitine Market set to hit $828.6 million by 2035
Industry revenue for Levocarnitine is estimated to rise to $828.6 million by 2035 from $362.7 million of 2024. The revenue growth of market players is expected to average at 7.8% annually for the period 2024 to 2035.September 2, 2025
Levoketoconazole Market set to hit $461.6 million by 2035
Industry revenue for Levoketoconazole is estimated to rise to $461.6 million by 2035 from $194.0 million of 2024. The revenue growth of market players is expected to average at 8.2% annually for the period 2024 to 2035.September 2, 2025
Lotilaner Market set to hit $938.2 million by 2035
Industry revenue for Lotilaner is estimated to rise to $938.2 million by 2035 from $432.2 million of 2024. The revenue growth of market players is expected to average at 7.3% annually for the period 2024 to 2035.September 2, 2025
Lonapegsomatropin Market set to hit $418.3 million by 2035
Industry revenue for Lonapegsomatropin is estimated to rise to $418.3 million by 2035 from $179.4 million of 2024. The revenue growth of market players is expected to average at 8.0% annually for the period 2024 to 2035.September 2, 2025
Levomilnacipran Hydrochloride Market set to hit $305.2 million by 2035
Industry revenue for Levomilnacipran Hydrochloride is estimated to rise to $305.2 million by 2035 from $145.0 million of 2024. The revenue growth of market players is expected to average at 7.0% annually for the period 2024 to 2035.September 2, 2025
Lithium Phosphate Market set to hit $490.8 million by 2035
Industry revenue for Lithium Phosphate is estimated to rise to $490.8 million by 2035 from $202.1 million of 2024. The revenue growth of market players is expected to average at 8.4% annually for the period 2024 to 2035.September 2, 2025
Loncastuximab Tesirine Market set to hit $400.6 million by 2035
Industry revenue for Loncastuximab Tesirine is estimated to rise to $400.6 million by 2035 from $144.7 million of 2024. The revenue growth of market players is expected to average at 9.7% annually for the period 2024 to 2035.September 2, 2025
Lorlatinib Market set to hit $870.1 million by 2035
Industry revenue for Lorlatinib is estimated to rise to $870.1 million by 2035 from $358.3 million of 2024. The revenue growth of market players is expected to average at 8.4% annually for the period 2024 to 2035.September 2, 2025
Levoleucovorin Calcium Market set to hit $450.3 million by 2035
Industry revenue for Levoleucovorin Calcium is estimated to rise to $450.3 million by 2035 from $237.2 million of 2024. The revenue growth of market players is expected to average at 6.0% annually for the period 2024 to 2035.September 2, 2025
Lithium Sulfate Market set to hit $735.2 million by 2035
Industry revenue for Lithium Sulfate is estimated to rise to $735.2 million by 2035 from $262.9 million of 2024. The revenue growth of market players is expected to average at 9.8% annually for the period 2024 to 2035.September 2, 2025
Loteprednol Etabonate Market set to hit $360.1 million by 2035
Industry revenue for Loteprednol Etabonate is estimated to rise to $360.1 million by 2035 from $206.2 million of 2024. The revenue growth of market players is expected to average at 5.2% annually for the period 2024 to 2035.September 2, 2025
Levoleucovorin Disodium Market set to hit $421.3 million by 2035
Industry revenue for Levoleucovorin Disodium is estimated to rise to $421.3 million by 2035 from $217.4 million of 2024. The revenue growth of market players is expected to average at 6.2% annually for the period 2024 to 2035.September 2, 2025
Lorlatinib Market set to hit $870.1 million by 2035
Industry revenue for Lorlatinib is estimated to rise to $870.1 million by 2035 from $358.3 million of 2024. The revenue growth of market players is expected to average at 8.4% annually for the period 2024 to 2035.September 1, 2025
Lithium Phosphate Market set to hit $490.8 million by 2035
Industry revenue for Lithium Phosphate is estimated to rise to $490.8 million by 2035 from $202.1 million of 2024. The revenue growth of market players is expected to average at 8.4% annually for the period 2024 to 2035.September 1, 2025
Levoleucovorin Calcium Market set to hit $450.3 million by 2035
Industry revenue for Levoleucovorin Calcium is estimated to rise to $450.3 million by 2035 from $237.2 million of 2024. The revenue growth of market players is expected to average at 6.0% annually for the period 2024 to 2035.September 1, 2025
Lithium Sulfate Market set to hit $735.2 million by 2035
Industry revenue for Lithium Sulfate is estimated to rise to $735.2 million by 2035 from $262.9 million of 2024. The revenue growth of market players is expected to average at 9.8% annually for the period 2024 to 2035.September 1, 2025
Loteprednol Etabonate Market set to hit $360.1 million by 2035
Industry revenue for Loteprednol Etabonate is estimated to rise to $360.1 million by 2035 from $206.2 million of 2024. The revenue growth of market players is expected to average at 5.2% annually for the period 2024 to 2035.September 1, 2025
Levoleucovorin Disodium Market set to hit $421.3 million by 2035
Industry revenue for Levoleucovorin Disodium is estimated to rise to $421.3 million by 2035 from $217.4 million of 2024. The revenue growth of market players is expected to average at 6.2% annually for the period 2024 to 2035.September 1, 2025
Lonapegsomatropin Market set to hit $418.3 million by 2035
Industry revenue for Lonapegsomatropin is estimated to rise to $418.3 million by 2035 from $179.4 million of 2024. The revenue growth of market players is expected to average at 8.0% annually for the period 2024 to 2035.September 1, 2025
Lovotibeglogene Autotemcel Market set to hit $1063.3 million by 2035
Industry revenue for Lovotibeglogene Autotemcel is estimated to rise to $1063.3 million by 2035 from $308.7 million of 2024. The revenue growth of market players is expected to average at 11.9% annually for the period 2024 to 2035.September 1, 2025
Lotilaner Market set to hit $938.2 million by 2035
Industry revenue for Lotilaner is estimated to rise to $938.2 million by 2035 from $432.2 million of 2024. The revenue growth of market players is expected to average at 7.3% annually for the period 2024 to 2035.September 1, 2025
Levocarnitine Market set to hit $828.6 million by 2035
Industry revenue for Levocarnitine is estimated to rise to $828.6 million by 2035 from $362.7 million of 2024. The revenue growth of market players is expected to average at 7.8% annually for the period 2024 to 2035.September 1, 2025
Loncastuximab Tesirine Market set to hit $400.6 million by 2035
Industry revenue for Loncastuximab Tesirine is estimated to rise to $400.6 million by 2035 from $144.7 million of 2024. The revenue growth of market players is expected to average at 9.7% annually for the period 2024 to 2035.September 1, 2025
Levoketoconazole Market set to hit $461.6 million by 2035
Industry revenue for Levoketoconazole is estimated to rise to $461.6 million by 2035 from $194.0 million of 2024. The revenue growth of market players is expected to average at 8.2% annually for the period 2024 to 2035.September 1, 2025
Levomilnacipran Hydrochloride Market set to hit $305.2 million by 2035
Industry revenue for Levomilnacipran Hydrochloride is estimated to rise to $305.2 million by 2035 from $145.0 million of 2024. The revenue growth of market players is expected to average at 7.0% annually for the period 2024 to 2035.September 1, 2025
Magnesium Iodide Market set to hit $231.4 million by 2035
Industry revenue for Magnesium Iodide is estimated to rise to $231.4 million by 2035 from $133.9 million of 2024. The revenue growth of market players is expected to average at 5.1% annually for the period 2024 to 2035.August 29, 2025
Loxapine Market set to hit $600.7 million by 2035
Industry revenue for Loxapine is estimated to rise to $600.7 million by 2035 from $303.6 million of 2024. The revenue growth of market players is expected to average at 6.4% annually for the period 2024 to 2035.August 29, 2025
Macitentan Market set to hit $1342.4 million by 2035
Industry revenue for Macitentan is estimated to rise to $1342.4 million by 2035 from $618.4 million of 2024. The revenue growth of market players is expected to average at 7.3% annually for the period 2024 to 2035.August 29, 2025
Magnesium Acetate Tetrahydrate Market set to hit $269.0 million by 2035
Industry revenue for Magnesium Acetate Tetrahydrate is estimated to rise to $269.0 million by 2035 from $157.3 million of 2024. The revenue growth of market players is expected to average at 5.0% annually for the period 2024 to 2035.August 29, 2025
Magnesium Fluoride Market set to hit $350.4 million by 2035
Industry revenue for Magnesium Fluoride is estimated to rise to $350.4 million by 2035 from $186.5 million of 2024. The revenue growth of market players is expected to average at 5.9% annually for the period 2024 to 2035.August 29, 2025
Magnesium Bromate Market set to hit $195.4 million by 2035
Industry revenue for Magnesium Bromate is estimated to rise to $195.4 million by 2035 from $111.9 million of 2024. The revenue growth of market players is expected to average at 5.2% annually for the period 2024 to 2035.August 29, 2025
Loxapine Succinate Market set to hit $443.4 million by 2035
Industry revenue for Loxapine Succinate is estimated to rise to $443.4 million by 2035 from $228.8 million of 2024. The revenue growth of market players is expected to average at 6.2% annually for the period 2024 to 2035.August 29, 2025
Luspatercept Market set to hit $583.9 million by 2035
Industry revenue for Luspatercept is estimated to rise to $583.9 million by 2035 from $247.9 million of 2024. The revenue growth of market players is expected to average at 8.1% annually for the period 2024 to 2035.August 29, 2025
Mafenide Acetate Market set to hit $432.5 million by 2035
Industry revenue for Mafenide Acetate is estimated to rise to $432.5 million by 2035 from $232.6 million of 2024. The revenue growth of market players is expected to average at 5.8% annually for the period 2024 to 2035.August 29, 2025
Magnesium Arsenate Market set to hit $243.3 million by 2035
Industry revenue for Magnesium Arsenate is estimated to rise to $243.3 million by 2035 from $135.0 million of 2024. The revenue growth of market players is expected to average at 5.5% annually for the period 2024 to 2035.August 29, 2025
Macimorelin Market set to hit $577.5 million by 2035
Industry revenue for Macimorelin is estimated to rise to $577.5 million by 2035 from $212.8 million of 2024. The revenue growth of market players is expected to average at 9.5% annually for the period 2024 to 2035.August 29, 2025
Lusutrombopag Market set to hit $451.4 million by 2035
Industry revenue for Lusutrombopag is estimated to rise to $451.4 million by 2035 from $221.2 million of 2024. The revenue growth of market players is expected to average at 6.7% annually for the period 2024 to 2035.August 29, 2025
Lumateperone Market set to hit $829.3 million by 2035
Industry revenue for Lumateperone is estimated to rise to $829.3 million by 2035 from $293.6 million of 2024. The revenue growth of market players is expected to average at 9.9% annually for the period 2024 to 2035.August 29, 2025
Manganese Acetate Tetrahydrate Market set to hit $490.5 million by 2035
Industry revenue for Manganese Acetate Tetrahydrate is estimated to rise to $490.5 million by 2035 from $216.9 million of 2024. The revenue growth of market players is expected to average at 7.7% annually for the period 2024 to 2035.August 28, 2025
Maribavir Market set to hit $481.9 million by 2035
Industry revenue for Maribavir is estimated to rise to $481.9 million by 2035 from $238.6 million of 2024. The revenue growth of market players is expected to average at 6.6% annually for the period 2024 to 2035.August 28, 2025
Manganese Nitrate Tetrahydrate Market set to hit $458.5 million by 2035
Industry revenue for Manganese Nitrate Tetrahydrate is estimated to rise to $458.5 million by 2035 from $249.2 million of 2024. The revenue growth of market players is expected to average at 5.7% annually for the period 2024 to 2035.August 28, 2025
Margetuximab Market set to hit $456.2 million by 2035
Industry revenue for Margetuximab is estimated to rise to $456.2 million by 2035 from $240.3 million of 2024. The revenue growth of market players is expected to average at 6.0% annually for the period 2024 to 2035.August 28, 2025
Manganese Carbonate Market set to hit $454.4 million by 2035
Industry revenue for Manganese Carbonate is estimated to rise to $454.4 million by 2035 from $211.5 million of 2024. The revenue growth of market players is expected to average at 7.2% annually for the period 2024 to 2035.August 28, 2025
Manganese Difluoride Market set to hit $447.0 million by 2035
Industry revenue for Manganese Difluoride is estimated to rise to $447.0 million by 2035 from $235.5 million of 2024. The revenue growth of market players is expected to average at 6.0% annually for the period 2024 to 2035.August 28, 2025
Magnesium Nitrite Market set to hit $250.5 million by 2035
Industry revenue for Magnesium Nitrite is estimated to rise to $250.5 million by 2035 from $143.4 million of 2024. The revenue growth of market players is expected to average at 5.2% annually for the period 2024 to 2035.August 28, 2025